Efficacy of octreotide in diarrhoea due to Vibrio cholerae: A randomized, controlled trial

Annals of Tropical Medicine and Parasitology

Volumn 90, Issue 5, 1996, Pages 507-513

  Abbas, Z ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HYPOTHALAMUS RELEASE INHIBITING FACTOR; OCTREOTIDE; OFLOXACIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHOLERA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DRUG EFFICACY; FEMALE; FLUID THERAPY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIBRIO CHOLERAE;

VIBRIO CHOLERAE;

EID: 0029959706     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034983.1996.11813076     Document Type: Article

References (4)

1. 2, and cyclic adenosine monophosphate in cholera toxin induced secretion in the small intestine of rats in vivo. Gastroenterology, 96, 368-376.
2. COOPER, J. Q, WILLIAMS, N. S., KING, R. F. & BARKER, M. C. (1986). Effects of a long acting somatostatin analogue in patients with severe ileostomy diarrhoea. British Journal of Surgery, 73, 128-131.
3. DUENO, M. I., BAI, J. C, SANTOANGELO, W. C. & KREJS, G. J. (1987). Effects of somatostatin analog on water and electrolyte transport and transit time in human small bowel. Digestive Diseases and Sciences, 32, 1092-1096.
4. FEDORAK, R. N. & ALLEN, S. L. (1989). Effect of somatostatin analog (SMS 201-995) on in vivo intestinal fluid transport in rats. A limited systemic effect. Digestire Diseases and Sciences, 34, 567-572.